BRY
Payout Frequency Quarterly

Dividend History

Pay DateAmountEx-DateRecord Date
December 4, 2025$0.032025-11-182025-11-18
August 28, 2025$0.032025-08-182025-08-18
May 29, 2025$0.032025-05-192025-05-19
April 1, 2025$0.032025-03-212025-03-22
November 25, 2024$0.032024-11-152024-11-15

Dividends Summary

Company News

Berry Stockholders Approve Combination with CRC
Benzinga • Globe Newswire • December 15, 2025

Berry Corporation shareholders voted to approve a merger with California Resources Corporation, with approximately 73% of outstanding shares and 98% of voted shares supporting the transaction. The merger will involve exchanging 0.0718 shares of CRC for each Berry share, with closing expected on December 18.

Halper Sadeh LLC Encourages EVOK, FSFG, BRY Shareholders to Contact the Firm to Discuss Their Rights
GlobeNewswire Inc. • Halper Sadeh Llc • December 2, 2025

Law firm investigating potential securities law violations and fiduciary duty breaches for three companies undergoing mergers or acquisitions.

$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger—TRUE, BRY, EVOK, and FSFG
GlobeNewswire Inc. • Juan Monteverde • December 1, 2025

Law firm Monteverde & Associates is investigating merger transactions for multiple companies, alerting shareholders about potential legal actions related to recent corporate sales and mergers.

Halper Sadeh LLC Encourages CMA, BRY, COMP, HOUS Shareholders to Contact the Firm to Discuss Their Rights
GlobeNewswire Inc. • Halper Sadeh Llc • November 20, 2025

Law firm investigating potential securities law violations and fiduciary duty breaches for several companies involved in mergers and acquisitions.

SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger-HOUS, CRTAF, BRY, and AKRO
Benzinga • Juan Monteverde • November 18, 2025

Law firm Monteverde & Associates is investigating potential merger-related class action lawsuits for several companies, including Anywhere Real Estate, Cartica Acquisition, Berry Corporation, and Akero Therapeutics.

Related Companies